SBIR/STTR Research Award
SBIR Phase I: Hybrid stochastic-deterministic method for modeling molecular and morphological structures of materials
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2005Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- RES Group, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- MEHSK81BKN87
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
This Small Business Innovation Research Phase I project will prototype a novel modeling technology--the Hybrid Stochastic-Deterministic Method--for use in precise modeling of molecular and morphological structures of advanced materials. Because the evolution of molecular and morphological structure is complex, mathematical modeling is an invaluable tool for product and process development and optimization. The current state of the art modeling technologies cannot predict the complete structural information required by the industry. This proposal presents a novel and unique method for integrating the state of the art techniques from deterministic and stochastic mathematical sciences in the modeling and simulation of materials. The result of the proposed work, commercial modeling software, has the potential for significant economic impact because it addresses an important need in large industries such as the polymer industry. The modeling technique is also relevant to other chemical industries and to the pharmaceutical industry.. The proposed work has the potential to spawn a new multidisciplinary research field and education curriculum, currently not covered by those using the deterministic or stochastic method alone; and to make a technological impact in solving other mathematically equivalent modeling problems such as nanoparticle synthesis and biological cellular systems.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Numerical Tools for Predicting Drug Dissolution Profiles
- Numerical Tools for Predicting Drug Dissolution Profiles
- SBIR Phase I: BioPath Finder: An integrative workflow for the design, construction and analysis of biological pathways
- SBIR Phase II: OpenBio Workbench for Sharing of Mathematical Models in Drug Discovery
- SBIR Phase II: Engine Combustion Simulator